DIPENTUM olsalazine sodium capsule gelatin coated Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

dipentum olsalazine sodium capsule gelatin coated

alaven pharmaceutical llc - olsalazine sodium (unii: y7jew0xg7i) (olsalazine - unii:uls5i8j03o) - olsalazine sodium 250 mg

DIPENTUM olsalazine sodium 500mg tablet bottle Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

dipentum olsalazine sodium 500mg tablet bottle

atnahs pharma australia pty ltd - olsalazine sodium, quantity: 500 mg - tablet, uncoated - excipient ingredients: povidone; crospovidone; colloidal anhydrous silica; magnesium stearate; ethanol - indications: treatment of ulcerative colitis in patients intolerant of sulphasalazine.

Dipentum 250mg hard Capsules Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

dipentum 250mg hard capsules

atnahs pharma netherlands b.v. - olsalazine sodium - capsule, hard - 250 milligram(s) - aminosalicylic acid and similar agents; olsalazine

DIPENTUM CAPSULE Kanada - Inggeris - Health Canada

dipentum capsule

atnahs pharma uk limited - olsalazine sodium - capsule - 250mg - olsalazine sodium 250mg - anti-inflammatory agents

Dipentum 250mg Capsules Australia - Inggeris - Department of Health (Therapeutic Goods Administration)

dipentum 250mg capsules

atnahs pharma australia pty ltd - olsalazine sodium, quantity: 250 mg - capsule - excipient ingredients: titanium dioxide; gelatin; magnesium stearate; caramel; propylene glycol; butan-1-ol; isopropyl alcohol; strong ammonia solution; iron oxide black; ethanol; shellac; sulfuric acid; purified water; industrial methylated spirit; ammonia - indications as at 19 december 2000: treatment of ulcerative colitis in patients intolerant of sulphasalazine.

DIPENTUM olsalazine sodium capsule Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

dipentum olsalazine sodium capsule

ucb, inc. - olsalazine sodium (unii: y7jew0xg7i) (olsalazine - unii:uls5i8j03o) - 250 mg

Dipentum New Zealand - Inggeris - Medsafe (Medicines Safety Authority)

dipentum

clinect nz pty limited - olsalazine sodium 500mg (plus overage 1.2%) - tablet - 500 mg - active: olsalazine sodium 500mg (plus overage 1.2%) excipient: colloidal silicon dioxide crospovidone magnesium stearate povidone

Dipentum 250mg hard Capsules Ireland - Inggeris - HPRA (Health Products Regulatory Authority)

dipentum 250mg hard capsules

atnahs pharma uk limited - olsalazine sodium - capsule - 250 milligram(s) - aminosalicylic acid and similar agents; olsalazine